This website is now the new JPND's archival platform. This website hosts all of JPND's archived content and resources.
Please continue to visit this site to access publications, videos and reports from JPND's activities.
Name of policy right to decide end of life policy Please briefly describe the policy decide end of life policy. Is this policy about: Both health and social care Does this policy cover: The care of people having a neurodegenerative…
The mis-folded and infectious prion protein that is a marker for variant Creutzfeldt-Jakob disease – linked to the consumption of infected cattle meat – has been detected in the urine of patients with the disease by researchers at The…
Nutritional shortcomings are a key driver of age-related decline and disability whereas proper diet can increase years of healthy life. In support of the European Innovation Partnership on Active and Healthy Ageing, Joint Research Centre (JRC) scientists have reviewed the…
The 2CARE study of coenzyme Q for Huntington’s disease was halted early because an analysis of the results to date showed that it was very unlikely to show positive results. The study, called 2CARE, was designed to test whether a treatment…
The Austrian biotech AFFiRiS AG announced positive results of its Phase I safety trial of a vaccine against alpha-synuclein. Alpha-synuclein is the sticky protein that clumps in the cells of people with Parkinson’s, and AFFiRiS hopes to stop disease by…
The priorities of the Italian EU Presidency were recently published under the title “Europe: a Fresh Start”. For health-related priorities, special importance is being dedicated to the prevention of respiratory diseases, cancer, HIV and consideration of vaccines as an effective tool for…
An article published in the journal Nature Medicine describes that tau protein isoforms of subjects with Huntington’s disease are similar to those produced in known tauopathies (frontotemporal dementia, Alzheimer’s disease, progressive supranuclear palsy and corticobasal degeneration) This results in an imbalance in…
Gardens in care homes could be crucial in helping to stimulate memories for dementia patients, scientists have found. A Systematic Review of Quantitative and Qualitative Evidence entitled “What Is the Impact of Using Outdoor Spaces Such as Gardens on the…
Researchers from the Banner Alzheimer’s Institute in Phoenix introduced Novartis Pharmaceuticals Corporation as their partner in the upcoming Alzheimer’s Prevention Initiative ApoE4 trial. Banner will work with the Swiss pharmaceutical company to test experimental therapies in people who carry two…
One in three cases of Alzheimer’s disease worldwide is preventable, according to research from the University of Cambridge. The main risk factors for Alzheimer’s disease are a lack of exercise, smoking, depression and poor education, the study says. Previous research from 2011 put…
